Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or Dyslipidemia

NCT06647888 · clinicaltrials.gov ↗

RECRUITING

Status

12000

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Envlo Tablet
DRUG: Envlomet SR Tablet

Sponsor

Daewoong Pharmaceutical Co. LTD.